2023 Form 5500 filing — Blueprint Medicines Corporation 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240919124604NAL0010494224001) for Blueprint Medicines Corporation 401(K) Plan, reported by Blueprint Medicines Corporation under EIN 26-3632015 and plan number 001. It reports 710 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240919124604NAL0010494224001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Blueprint Medicines Corporation
- EIN
- 26-3632015
- Plan number
- 001
- Location
- Cambridge, MA
- Participants
- 710
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $73,203,896
- Net assets (EOY)
- $73,203,896
- Employer contributions
- $4,559,709
- Participant contributions
- $10,634,810
- Total income / additions
- $29,077,145
- Benefits paid
- $3,927,248
- Administrative expenses
- $87,743
- Total expenses
- $4,014,991
- Net increase / (decrease)
- $25,062,154
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Cambridge Investment Research | BROKER DEALER OF ADVISOR | $86,033 | not reported in the loaded dataset |
| The Vanguard Group, Inc. | RECORD KEEPER | $5,360 | not reported in the loaded dataset |